Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Flamma SpA
Flamma SpA
Activities:
Manufacturing
X
LinkedIn
Trending Articles
Pfizer appoints Chris Boshoff as Chief Scientific Officer and President of R&D
Dr Boshoff will be responsible for overseeing and advancing Pfizer's R&D initiatives across all therapeutic areas
Servier opens new €86m biologics production facility in Loiret, France
The company's Bio-S facility will be responsible for the production of biological medicines stemming from its R&D pipeline for preclinical and clinical studies
You need to be a subscriber to read this article.
Click here
to find out more.
Hybrid interferons: developing a novel drug class
With many hurdles to overcome, establishing a new drug candidate is a long process — particularly if you are a smaller biotech company with limited resources. These...
Leybold launches Duradry vacuum pump for harsh processes
Advanced technology designed for reliability and efficiency
2BScientific expands its life science product supply service to Europe with new German facility
The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies
Upcoming event
CPhI Middle East
10–12 December 2024 | Conference | Riyadh, Saudi Arabia
See all
Related Content
Manufacturing
Italian CDMO Flamma arrives in the US
The Italian small molecule API manufacturer has acquired Teva’s cGMP chemical synthesis centre in Philadephia
Flamma opens new cGMP Kilo Lab suite at Italian headquarters
API manufacturer has also announced plans for new R&D building at the Chignolo site
Subscribe now